SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Enzon Pharmaceuticals, Inc. Presents Final Analysis of Phase II PEG-SN38 (EZN-2208) Study in Patients With Metastatic Breast Cancer at 2012 American Society of Clinical Oncology Meeting